Notably, miRNA‐mRNA regulation in HDAC2‐downregulated cells was comparable after both enzymatic and pharmacological inhibition by SAHA, supporting the hypothesis that upregulated expression levels of HDAC2 indicate dysfunction of these regulators in AML. The gene discussed is HDAC2; the disease is acute myeloid leukemia.